175 related articles for article (PubMed ID: 29307199)
1. Pathologic classification of "pancreatic cancers": current concepts and challenges.
Mostafa ME; Erbarut-Seven I; Pehlivanoglu B; Adsay V
Chin Clin Oncol; 2017 Dec; 6(6):59. PubMed ID: 29307199
[TBL] [Abstract][Full Text] [Related]
2. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
[TBL] [Abstract][Full Text] [Related]
3. Histopathologic assessment of pancreatic cancer: does one size fit all?
Reid MD; Bagci P; Adsay NV
J Surg Oncol; 2013 Jan; 107(1):67-77. PubMed ID: 22711682
[TBL] [Abstract][Full Text] [Related]
4. Ampullary region carcinomas: definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases.
Adsay V; Ohike N; Tajiri T; Kim GE; Krasinskas A; Balci S; Bagci P; Basturk O; Bandyopadhyay S; Jang KT; Kooby DA; Maithel SK; Sarmiento J; Staley CA; Gonzalez RS; Kong SY; Goodman M
Am J Surg Pathol; 2012 Nov; 36(11):1592-608. PubMed ID: 23026934
[TBL] [Abstract][Full Text] [Related]
5. Pathologic staging of pancreatic, ampullary, biliary, and gallbladder cancers: pitfalls and practical limitations of the current AJCC/UICC TNM staging system and opportunities for improvement.
Adsay NV; Bagci P; Tajiri T; Oliva I; Ohike N; Balci S; Gonzalez RS; Basturk O; Jang KT; Roa JC
Semin Diagn Pathol; 2012 Aug; 29(3):127-41. PubMed ID: 23062420
[TBL] [Abstract][Full Text] [Related]
6. Malignant epithelial/exocrine tumors of the pancreas.
Luchini C; Grillo F; Fassan M; Vanoli A; Capelli P; Paolino G; Ingravallo G; Renzulli G; Doglioni C; D'Amuri A; Mattiolo P; Pecori S; Parente P; Florena AM; Zamboni G; Scarpa A
Pathologica; 2020 Sep; 112(3):210-226. PubMed ID: 33179623
[TBL] [Abstract][Full Text] [Related]
7. Rare ductal adenocarcinoma of the pancreas in patients younger than age 40 years.
Lüttges J; Stigge C; Pacena M; Klöppel G
Cancer; 2004 Jan; 100(1):173-82. PubMed ID: 14692038
[TBL] [Abstract][Full Text] [Related]
8. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
[TBL] [Abstract][Full Text] [Related]
9. Significance of mucin expression in pancreatobiliary neoplasms.
Yonezawa S; Higashi M; Yamada N; Yokoyama S; Goto M
J Hepatobiliary Pancreat Sci; 2010 Mar; 17(2):108-24. PubMed ID: 19787286
[TBL] [Abstract][Full Text] [Related]
10. Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms.
Sahora K; Crippa S; Zamboni G; Ferrone C; Warshaw AL; Lillemoe K; Mino-Kenudson M; Falconi M; Fernandez-del Castillo C
Eur J Surg Oncol; 2016 Feb; 42(2):197-204. PubMed ID: 26687069
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic ductal adenocarcinoma: prevalence and diagnostic value of dark choledochal ring sign on T2-weighted MRI.
Cha DI; Kim YK; Choi SY; Lim SH; Choi D; Lee WJ
Clin Radiol; 2014 Apr; 69(4):416-23. PubMed ID: 24457015
[TBL] [Abstract][Full Text] [Related]
12. Pathology and Molecular Characteristics of Pancreatic Cancer.
Kearney JF; Adsay V; Yeh JJ
Surg Oncol Clin N Am; 2021 Oct; 30(4):609-619. PubMed ID: 34511185
[TBL] [Abstract][Full Text] [Related]
13. Adenocarcinoma of the minor duodenal papilla and its precursor lesions: a clinical and pathologic study.
Shia J; Agaram NP; Olgac S; Cobanov B; Adsay V; Klimstra DS
Am J Surg Pathol; 2014 Apr; 38(4):526-33. PubMed ID: 24625417
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of multiple types of pancreatico-biliary tumors by molecular analysis of clinical specimens.
Gress TM; Kestler HA; Lausser L; Fiedler L; Sipos B; Michalski CW; Werner J; Giese N; Scarpa A; Buchholz M
J Mol Med (Berl); 2012 Apr; 90(4):457-64. PubMed ID: 22119958
[TBL] [Abstract][Full Text] [Related]
15. Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma.
Janky R; Binda MM; Allemeersch J; Van den Broeck A; Govaere O; Swinnen JV; Roskams T; Aerts S; Topal B
BMC Cancer; 2016 Aug; 16():632. PubMed ID: 27520560
[TBL] [Abstract][Full Text] [Related]
16. Hilar cholangiocarcinoma is pathologically similar to pancreatic duct adenocarcinoma: suggestions of similar background and development.
Nakanuma Y; Sato Y
J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):441-7. PubMed ID: 24446421
[TBL] [Abstract][Full Text] [Related]
17. Acinar neoplasms of the pancreas-A summary of 25 years of research.
Klimstra DS; Adsay V
Semin Diagn Pathol; 2016 Sep; 33(5):307-18. PubMed ID: 27320062
[TBL] [Abstract][Full Text] [Related]
18. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
Adsay NV; Basturk O; Cheng JD; Andea AA
Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
[TBL] [Abstract][Full Text] [Related]
19. Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases.
Adsay V; Jang KT; Roa JC; Dursun N; Ohike N; Bagci P; Basturk O; Bandyopadhyay S; Cheng JD; Sarmiento JM; Escalona OT; Goodman M; Kong SY; Terry P
Am J Surg Pathol; 2012 Sep; 36(9):1279-301. PubMed ID: 22895264
[TBL] [Abstract][Full Text] [Related]
20. BCL9L expression in pancreatic neoplasia with a focus on SPN: a possible explanation for the enigma of the benign neoplasia.
Hallas C; Phillipp J; Domanowsky L; Kah B; Tiemann K
BMC Cancer; 2016 Aug; 16():648. PubMed ID: 27539223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
